Skip to main content
. 2022 Apr;14(2):115–126. doi: 10.22122/AHJ.2022.196452.1287

Table 1. Patient Demographics and Risk Factors for Laryngeal Cancer .

Variables Non-RD
N=290 		RD
N=39 		RR(95% CI) p-value
Sex

  • Male

  • Female
226 (77.9%)
64 (22.1%)
25 (64.1%)
14 (35.9%)
0.82 (0.65-1.05)
1.63(1.01-2.61)
0.088X2
Follow-up month (IQR) 24.0 (11.0, 31.0) 24.0 (10.0, 35.5) Not relevant 0.800mann-whitney
Age (SD)

  • <55

  • 55-70

  • >70

66.6 (9.86)
38 (13.1%)
152 (52.4%)
100 (34.5%)		 53.0 (11.2)
27 (69.23%)
7 (17.95%)
5 (12.82%)		 -
5.28(3.68-7.59)
0.34(0.17-0.68)
0.37(0.16-0.86)		 <0.001welcht-test

<0.001X2
BMI kg/m 2 (IQR)

  • <18.5

  • 18.5-30

  • >30

 25.0 (22.0, 29.0)
19 (7.20%)
203 (76.9%)
42 (15.9%)		 24.0 (20.8, 27.2)
5 (13.9%)
26 (72.2%)
5 (13.9%)		 -
1.93(0.77-4.85)
0.94(0.76-1.16)
0.87(0.37-2.06)		 0.202mann-whitney

0.378X2
ASA

  • 1

  • 2

  • 3

  • 4


13 (6.5%)
60 (30.2%)
119 (59.8%)
7 (3.5%)
0 (0.00%)
8 (26.7%)
19 (63.3%)
3 (10.0%)
Not available
0.88(0.47-1.66)
1.06(0.79-1.42)
2.84(0.78-10.40)		 0.201f
SIMD16 Quintile Grouping

  • 1+2

  • 3

  • 4+5

204 (73.65%)
20 (7.22%)
53 (19.13%)

35 (92.1%)
1 (2.63%)
2 (5.26%)

1.25(1.11-1.41)
0.36(0.05-2.64)
0.28(0.07-1.08)

0.035f
Cigarette use

  • No

  • Ex

  • Yes
26 (8.96%)
93 (32.07%)
171 (58.97%)
1 (2.6%)
5 (12.8%)
33 (84.6%)
Not available
1.38 (0.17-11.3)
4.37 (0.62-30.7)
0.007fisherexact
Alcohol

  • No

  • Ex

  • Yes
69 (23.79%)
28 (9.66%)
193 (66.55%)
14 (35.9%)
4 (10.3%)
21 (53.8%)
Not available
0.74 (0.26-2.08)
0.58 (0.31-1.09)		 0.214fisherexact
BBV

  • Negative

  • Positive
287 (99%)
3 (1.03%)
28 (71.8%)
11 (28.2%)
0.73(0.60-0.88)
27.26
(7.95-93.47)		 <0.001X2
Stage

  • 1

  • 2

  • 3

  • 4
74 (25.51%)
62 (21.37%)
77 (26.56%)
77 (26.56%)
4 (10.3%)
3 (7.7%)
9 (23.0%)
23 (59.0%)
0.40(0.16-1.04)
0.36(0.12-1.09)
0.87(0.48-1.59)
2.22(1.61-3.07)		 <0.001X2
Laryngeal Cancer Subsite

  • Glottic

  • Subglottic

  • Supraglottic

  • Transglottic

125 (43.1%)
3 (1.03%)
121 (41.73%)
41 (14.13%)

9 (23.1%)
1 (2. 6%)
24 (61.5%)
5 (12.8%)

0.54(0.30-0.96)
2.48(0.26-24.82)
1.47(1.11-1.96)
0.91(0.38-2.16)
0.041fisherexact
Enteral Support

  • No

  • Yes
151 (52.1%)
139 (47.9%)
12 (30.8%)
27 (69.2%)
0.59(0.36-0.96)
1.44(1.13-1.84)		 0.020X2
Treatment Intention

  • Curative

  • Palliative
226 (77.9%)
64 (22.1%)
31 (79.5%)
8 (20.5%)
1.02(0.86-1.21)
0.93(0.48-1.79)
0.988X2
Treatment Modalities

  • 1

  • 2

  • 3

  • Palliative


185 (63.8 %)
37 (12.8%)
4 (1.38%)
64 (22.1%)
18 (46.2%)
8 (20.5%)
5 (12.8%)
8 (20.5%)
0.72(0.51-1.03)
1.61(0.81-3.20)
9.29(2.61-33.15)
0.93(0.48-1.79)
0.002X2